Group One Trading’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-1,183,500
Closed -$205M 5596
2015
Q1
$205M Buy
1,183,500
+1,086,600
+1,121% +$160M 3.21% 2
2014
Q4
$11.1M Buy
96,900
+64,600
+200% +$7.83M 0.17% 110
2014
Q3
$5.05M Buy
32,300
+14,000
+77% +$2.03M 0.08% 292
2014
Q2
$2.26M Buy
18,300
+11,900
+186% +$1.32M 0.03% 626
2014
Q1
$663K Sell
6,400
-14,300
-69% -$1.46M 0.01% 1421
2013
Q4
$1.86M Buy
20,700
+11,400
+123% +$909K 0.03% 688
2013
Q3
$622K Buy
9,300
+9,000
+3,000% +$620K 0.01% 1424
2013
Q2
$20K Buy
+300
New +$17.2K ﹤0.01% 4092

Other funds holding SLXP

Group One Trading's SLXP Position: Q2 2015 in Review

Group One Trading sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 516,177 shares — an estimated $89.2M sold.

Group One Trading first reported a position in SLXP in Q3 2013 and held it in 6 quarters. The position peaked at $89.2M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Group One Trading reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Group One Trading sold 516,177 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $89.2M.
  • Group One Trading first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2013 and held it in 6 quarters.
  • Group One Trading's SALIX PHARMACEUTICALS LTD DEL position peaked at $89.2M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Group One Trading's 13F filing for Q2 2015, filed 11 Aug 2015.